209 related articles for article (PubMed ID: 6311559)
21. Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium.
Maki S; Konno T; Maeda H
Cancer; 1985 Aug; 56(4):751-7. PubMed ID: 3160453
[TBL] [Abstract][Full Text] [Related]
22. How can we avert hepatic vascular complications in SMANCS therapy for hepatocellular carcinoma?
Okada S
J Gastroenterol; 2000; 35(5):407-9. PubMed ID: 10832680
[No Abstract] [Full Text] [Related]
23. [Combined treatment with intra-arterial administration of oily anti-cancer agents and transcatheter arterial embolization--clinical and pathological study on 2 cases with resected small hepatoma].
Tokuyama K; Jinno K; Yumoto Y; Takasima S; Fukuda K; Moriwaki S; Maeda H; Shimamura Y
Gan No Rinsho; 1984 Jul; 30(8):955-64. PubMed ID: 6088831
[TBL] [Abstract][Full Text] [Related]
24. [Intra-arterial infusion of SMANCS for treatment of patients with hepatocellular carcinoma--adverse reactions and complications].
Sakaguchi T; Yoshimatsu S; Sagara K; Yamashita Y; Takahashi M
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():64-9. PubMed ID: 9512690
[TBL] [Abstract][Full Text] [Related]
25. [Prevention of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein].
Yamasaki K; Konno T; Miyauchi Y; Maeda H
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1224-8. PubMed ID: 3034169
[TBL] [Abstract][Full Text] [Related]
26. Anticancer effects of arterial administration of the anticancer agent SMANCS with lipiodol on metastatic lymph nodes.
Ohtsuka N; Konno T; Miyauchi Y; Maeda H
Cancer; 1987 May; 59(9):1560-5. PubMed ID: 3030530
[TBL] [Abstract][Full Text] [Related]
27. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
Hirashima N
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():125-32. PubMed ID: 9512700
[TBL] [Abstract][Full Text] [Related]
28. Reduction of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein.
Yamasaki K; Konno T; Miyauchi Y; Maeda H
Cancer Res; 1987 Feb; 47(3):852-5. PubMed ID: 3026619
[TBL] [Abstract][Full Text] [Related]
29. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
[TBL] [Abstract][Full Text] [Related]
30. [Two cases of long-term survival with hepatocellular carcinoma following targeting therapy with SMANCS/lipiodol].
Inoue Y; Nakamura H
Gan To Kagaku Ryoho; 1996 Jan; 23(1):99-101. PubMed ID: 8546478
[TBL] [Abstract][Full Text] [Related]
31. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma--second report].
Hirashima N; Itazu I; Nukaya H; Kimura H; Hasegawa I; Yoshimizu T; Nemoto S; Sakakibara K
Gan To Kagaku Ryoho; 1998 May; 25(6):873-9. PubMed ID: 9617326
[TBL] [Abstract][Full Text] [Related]
32. [Arterial infusion of SMANCS-Lipiodol for advanced hepatocellular carcinoma].
Miura K; Nakao N; Yoshimoto A; Yamano T; Inoue J; Takayasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():51-5. PubMed ID: 9512688
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma.
Jinno K; Moriwaki S; Tanada M; Wada T; Mandai K; Okada Y
Cancer Chemother Pharmacol; 1992; 31 Suppl():S7-12. PubMed ID: 1333912
[TBL] [Abstract][Full Text] [Related]
34. [Arterial administration of oily anticancer agents dissolved in lipiodol fluid in recurrence of hepatoma after hepatic resection and in metastatic liver cancer].
Ohtsuka N; Konno T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1351-8. PubMed ID: 2837992
[TBL] [Abstract][Full Text] [Related]
35. [Clinical experience of treatment of liver metastasis of renal cell carcinoma treated with SMANCS/Lipiodol therapy].
Umeda S; Ito K; Takahashi E; Kimura F; Sumitomo M; Kaji T; Hayakawa M; Asano T
Hinyokika Kiyo; 2010 Oct; 56(10):543-9. PubMed ID: 21063157
[TBL] [Abstract][Full Text] [Related]
36. Multiple hepatic infarction after transcatheter arterial infusion with SMANCS.
Abe S; Yamasaki T; Nakano K; Yoshikawa I; Tabaru A; Otsuki M
J Gastroenterol; 2001 Jun; 36(6):415-21. PubMed ID: 11428589
[TBL] [Abstract][Full Text] [Related]
37. [Arterial administration of SMANCS and other antitumor agents dissolved in lipiodol for various malignant solid tumors].
Konno T; Iwai K; Maki S; Tashiro S; Miyauchi Y; Maeda H; Yokoyama I
Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1151-6. PubMed ID: 6095018
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of hepatic artery occlusion after intra-arterial infusion of SMANCS in patients with hepatocellular carcinoma].
Sakaguchi T; Yoshimatsu S; Sagara K; Yamashita Y; Takahashi M
Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Oct; 58(12):700-4. PubMed ID: 9844406
[TBL] [Abstract][Full Text] [Related]
39. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
Jin-no K
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
[TBL] [Abstract][Full Text] [Related]
40. [Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol].
Konno T
Gan To Kagaku Ryoho; 1987 Feb; 14(2):373-80. PubMed ID: 3028275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
